ODDB.org: Open Drug Database

AstraZeneca AG - Imfinzi 120 mg/2.4 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	66548	Sequence	01
Product name	Imfinzi 120 mg/2.4 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FF03	ATC-Description
Introduction of Sequence	11.06.2018

Composition

durvalumabum 120 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2.4 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Durvalumabum	120mg / 2.4ml

BAG: Active Agent	Dose
Durvalumabum	120 mg

Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 80
Trehalosum Dihydricum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		509.61	570.65	A	SL	Yes

2025	©ywesee GmbH